Latest Sinai Stories

Drug associated with rapid antidepressant effect in largest clinical trial to date Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the Icahn School of Medicine at Mount Sinai. The antidepressant benefits of ketamine were seen within 24 hours, whereas traditional antidepressants can take days or weeks to demonstrate a...

Mount Sinai’s International Center for Health Outcomes and Innovation Research (InCHOIR) is the data-coordinating center for the trial. New York, nY (PRWEB) May 10, 2013 Today the National Institute of Neurological Disorders and Stroke (NINDS) announced that “A Randomized Trial of Unruptured Brain Arteriovenous Malformations” (ARUBA) has stopped enrolling patients because of higher than expected event rates in the interventional therapy arm. The International Center for Health...

‘Cureatr’ App Developed by Mount Sinai Hospital Resident Dr. Joseph Mayer New York (PRWEB) May 09, 2013 The Mount Sinai Medical Center has adopted an enterprise-grade mobile care-coordination mobile app called Cureatr, which was designed by a resident at the Mount Sinai Hospital, Joseph Mayer, MD. Mount Sinai has signed a multi-year contract to roll out the app to Mount Sinai clinicians. “Mount Sinai is the first major academic medical center to adopt Cureatr,” said Dr. Bruce J....

Mount Sinai Researcher Estimates that Lead Exposure Could Cause Mental Retardation in 6 in 1,000 Children Living Near the Sites New York, NY (PRWEB) May 07, 2013 Children living near toxic waste sites in lower and middle income countries such as India, Philippines and Indonesia may experience higher blood lead levels, resulting in a loss of IQ points and a higher incidence of mental retardation, according to a study presented today by Kevin Chatham-Stephens, MD, Pediatric Environmental...

MIAMI BEACH, Fla., May 3, 2013 /PRNewswire-USNewswire/ -- Moody's Investors Service has upgraded its investment grade ratings assigned to Mount Sinai Medical Center in Miami Beach, Florida from stable to positive. The rating outlook reflects a multi-year track record of improved financial performance and continues to reinforce the medical center's strong image as a healthcare leader. The upgrade follows a fundamentally improved operating profile with measurable volume capture in...

Dr. Henn, a Columbus, OH native, trained at Cedars-Sinai Medical Center in Los Angeles, CA and at the Leipzip Heart Center in Leipzig, Germany. Youngstown, OH (PRWEB) April 29, 2013 Humility of Mary Health Partners is proud to welcome Lucas W. Henn, MD. Dr. Henn joins HMHP Physician Associates from North Shore LIJ – Lenox Hill Hospital in New York City. Originally from Columbus, OH, Dr. Henn trained at Cedars-Sinai Medical Center in Los Angeles, CA and completed a year of training in...

Solar carport is part of new Advanced Health Sciences Pavilion LOS ANGELES, April 25, 2013 /PRNewswire/ -- Stellar Solar, one of California's leading commercial and residential solar integrators since 1998, added to their impressive resume of high profile commercial projects with the recent activation of a solar carport system that is part of Cedars-Sinai's new Advanced Health Sciences Pavilion. The system incorporates 1,190 ?240-watt panels in multiple locations atop the parking...

Mount Sinai Will Be the First Medical Center Sponsor of the Aspen Ideas Festival New York, NY (PRWEB) April 19, 2013 This month marks the 10th anniversary of the sequencing of the human genome and every day, biomedical scientists are working to usher in a new era of genomic medicine based on the insights we now have, said Kenneth L. Davis, MD, President and Chief Executive Officer of The Mount Sinai Medical Center, at a recent Aspen Ideas Festival event in New York City. “Biomedical...

MIAMI BEACH, Fla., April 2, 2013 /PRNewswire-USNewswire/ -- For the fourth year in a row, Mount Sinai Medical Center's mission-driven operations have brought positive earnings and reinforced the medical center's strong image as a healthcare leader and community resource. Mount Sinai's 2012 net revenues were $497.1 million in 2012, up from $484.9 million in the prior year, representing a 2.5 percent increase. This is due to an increase in cardiac-related procedures, outpatient surgical...

BRONX, N.Y., March 17, 2013 /PRNewswire-USNewswire/ -- Researchers at Albert Einstein College of Medicine of Yeshiva University and the Icahn School of Medicine at Mount Sinai have found that macrophages - white blood cells that play a key role in the immune response - also help to both produce and eliminate the body's red blood cells (RBCs). The findings could lead to novel therapies for diseases or conditions in which the red blood cell production is thrown out of balance. The...